Institut Paoli-Calmettes: Leukemia, Myeloid, Acute trials

The registry lists 17 Leukemia, Myeloid, Acute studies with Institut Paoli-Calmettes as lead sponsor. 2 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 1 4Phase 2 7No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• FLUDARABINE-TREOSULFAN REDUCED INTENSITY CONDITIONING REGIMEN PRIOR HAPLOIDENTICAL STEM CELL TRANSPLANTATION WITH POST TRANSPLANTATION CYCLOPHOSPHAMIDE FOR OLDER AND/OR FRAIL PATIENTS WITH AMLNot yet recruitingNCT07598110Phase 2
• De-Escalation Study Evaluating Venetoclax and Azacitidine Discontinuation in AML Responding PatientsRecruitingNCT06557421Phase 2
• Evaluation of DASATINIB Monotherapy Efficacy in Acute Myeloid Leukemia Patients Refractory to VENETOCLAX-AZACITIDINESuspendedNCT06055621Phase 2
• Study of Escalating Doses of INA03 Administered Intravenously as Single Agent in Adult Patients With Relapse/Refractory Acute LeukemiaCompletedNCT03957915Early Phase 1
• Early Prophylactic Donor Lymphocyte Infusion After Allo-HSCT for Patients With AMLActive, not recruitingNCT03597321Phase 2
• COaching and Prehabilitation: Faisability Study in Patients With Acute Myeloid Leukemia and Myelodysplastic SyndromeActive, not recruitingNCT03595787Not applicable
• Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelodysplastic SyndromesStatus unknownNCT03235973Phase 1
• HLA-mismatched Microtransplantation Without Immunosuppressive Treatment in Patients With Myeloid HemopathiesCompletedNCT03232268Phase 1
• Role of PTK-7 in Acute Myeloid LeukemiasCompletedNCT02860793Not applicable
• ChEmo-Genomics Based Treatment of Acute Myeloid LeukemiaStatus unknownNCT02619071Not applicable
• Pilot Study Immunomonitoring Natural Killers Cells in Patients With Myeloid Malignancies Treated With LenalidomideCompletedNCT02525250Not applicable
• Evaluation of Adverse Long-term Effects in Young Adult Survivors of Acute LeukemiaStatus unknownNCT02345915Not applicable
• Evaluation of 3 Different Doses of IV BusulfanCompletedNCT01985061Phase 2
• Phase I/II Study of Immune Therapy After Allograft in Patients With Myeloid HemopathyCompletedNCT01819558Phase 1/2
• Program of Evaluation and Geriatric Intervention on the Functional Status, Quality of the Life, and SurvivalStatus unknownNCT01188330Not applicable
• Laromustine, Daunorubicin, and Cytarabine in Treating Patients With Acute Myeloid LeukemiaCompletedNCT00840684Phase 1/2
• Natural Killer Cells in Older Patients With Acute Myeloid LeukemiaCompletedNCT00540956Not applicable